Weijia Lu

480 total citations
8 papers, 332 citations indexed

About

Weijia Lu is a scholar working on Pharmaceutical Science, Oncology and Small Animals. According to data from OpenAlex, Weijia Lu has authored 8 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pharmaceutical Science, 2 papers in Oncology and 1 paper in Small Animals. Recurrent topics in Weijia Lu's work include Veterinary Pharmacology and Anesthesia (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Advancements in Transdermal Drug Delivery (1 paper). Weijia Lu is often cited by papers focused on Veterinary Pharmacology and Anesthesia (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Advancements in Transdermal Drug Delivery (1 paper). Weijia Lu collaborates with scholars based in China, Mexico and Germany. Weijia Lu's co-authors include Xiao Zhu, Yi Qi, Jing Yao, Yu Zhao, Xue‐Jun Guo, Weijing Cai, Yuwen Lu, Yan Li, Li Liu and Zhong‐Yi Dong and has published in prestigious journals such as PLoS ONE, Biomaterials and Neural Networks.

In The Last Decade

Weijia Lu

8 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weijia Lu China 6 99 96 70 64 58 8 332
Hanliang Jiang China 12 154 1.6× 96 1.0× 183 2.6× 122 1.9× 103 1.8× 35 597
Rahaba Marima South Africa 10 88 0.9× 80 0.8× 139 2.0× 72 1.1× 40 0.7× 23 401
Andrea Gonsalves United States 7 36 0.4× 44 0.5× 77 1.1× 24 0.4× 75 1.3× 7 293
Dayoung Kim South Korea 8 61 0.6× 29 0.3× 72 1.0× 23 0.4× 36 0.6× 18 292
Liang Sang China 9 73 0.7× 31 0.3× 160 2.3× 21 0.3× 177 3.1× 38 500
Míchel Herranz Spain 11 127 1.3× 30 0.3× 61 0.9× 10 0.2× 73 1.3× 24 363
Wanheng Zhang China 11 48 0.5× 158 1.6× 128 1.8× 19 0.3× 61 1.1× 20 394
Subhajit Chatterjee India 15 43 0.4× 173 1.8× 253 3.6× 19 0.3× 43 0.7× 20 447
Chunmiao Chen China 10 74 0.7× 33 0.3× 160 2.3× 27 0.4× 53 0.9× 19 345
Mi Young Kim South Korea 13 269 2.7× 111 1.2× 97 1.4× 132 2.1× 57 1.0× 28 593

Countries citing papers authored by Weijia Lu

Since Specialization
Citations

This map shows the geographic impact of Weijia Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijia Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijia Lu more than expected).

Fields of papers citing papers by Weijia Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijia Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijia Lu. The network helps show where Weijia Lu may publish in the future.

Co-authorship network of co-authors of Weijia Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Weijia Lu. A scholar is included among the top collaborators of Weijia Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijia Lu. Weijia Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lu, Weijia, et al.. (2025). A novel self-supervised graph clustering method with reliable semi-supervision. Neural Networks. 187. 107418–107418. 1 indexed citations
2.
Su, Jing, Weijia Lu, Zhuoyi Liu, et al.. (2023). Depot unilamellar liposomes to sustain transscleral drug Co-delivery for ophthalmic infection therapy. Journal of Drug Delivery Science and Technology. 86. 104629–104629. 9 indexed citations
3.
4.
5.
Zhang, Ruixue, et al.. (2021). Nanoparticulate Drug Delivery Strategies to Address Intestinal Cytochrome P450 CYP3A4 Metabolism towards Personalized Medicine. Pharmaceutics. 13(8). 1261–1261. 24 indexed citations
6.
Lu, Weijia, Jing Yao, Xiao Zhu, & Yi Qi. (2020). Nanomedicines: Redefining traditional medicine. Biomedicine & Pharmacotherapy. 134. 111103–111103. 96 indexed citations
7.
Cao, Rui, Fan Yang, Si-Cong Ma, et al.. (2020). Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in Colorectal Cancer. Theranostics. 10(24). 11080–11091. 163 indexed citations
8.
Wang, Shuhui, Huajing Wang, Tiancheng Zhang, et al.. (2012). Potent Neutralization of Botulinum Neurotoxin/B by Synergistic Action of Antibodies Recognizing Protein and Ganglioside Receptor Binding Domain. PLoS ONE. 7(8). e43845–e43845. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hanliang Jiang Breakdown of academic impact, for papers by Rahaba Marima Breakdown of academic impact, for papers by Andrea Gonsalves Breakdown of academic impact, for papers by Dayoung Kim Breakdown of academic impact, for papers by Liang Sang Breakdown of academic impact, for papers by Míchel Herranz Breakdown of academic impact, for papers by Wanheng Zhang Breakdown of academic impact, for papers by Subhajit Chatterjee Breakdown of academic impact, for papers by Chunmiao Chen Breakdown of academic impact, for papers by Mi Young Kim
Rankless by CCL
2026